Recruiting studies: Sorafenib

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Clinical Study of Sorafenib Combined With Gefitinib for the Treatment of pNET
Phase N/A · 1 location(s) · Shanghai General Hospital, Shanghai Jiao Tong University Sch · NCT06592989 Clinical Pharmacogenetic Study of Sorafenib in Egyptian Patients With Hepatocellular Carcinoma
Phase 1/Phase 2 · 1 location(s) · Assiut University · NCT06527495 Sorafenib Relapase Prophylaxis After HCT With PTBCy Regimen
Phase 2 · 1 location(s) · St. Petersburg State Pavlov Medical University · NCT06532084 Adapting Treatment to the Tumor Molecular Alterations for Patients With Advanced Solid Tumors: MyOwnSpecificTreatment
Phase 2 · 7 location(s) · Centre Leon Berard · NCT02029001 Surufatinib Combined With Carboplatin/Paclitaxel and Surufatinib Combined With Olaparib as First-line and Maintenance Th
Phase 2 · 1 location(s) · Anhui Provincial Cancer Hospital · NCT06437353 Phase 2 Study of WGI-0301 for Advanced HCC
Phase 2 · 4 location(s) · Zhejiang Haichang Biotech Co., Ltd. · NCT06309485 Real World Study of Effectiveness of Sunitinib or Sorafenib to Chinese Unresectable Locally Advanced or Metastatic PRCC
Phase N/A · 1 location(s) · AstraZeneca · NCT07024680 SHIELD: Sorafenib Hand-foot Syndrome Inhibition With Pre-Emptive Local Delivery of Topical Indomethacin
Phase 2 · 1 location(s) · National Taiwan University Hospital · NCT07560566 MRD-guided Maintenance Post-HCT: Gilteritini vs Sorafenib
Phase 3 · 2 location(s) · The First Affiliated Hospital of Soochow University · NCT07463651 Safety and Efficacy of Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor Patients
Phase 1/Phase 2 · 2 location(s) · St. Jude Children's Research Hospital · NCT05468359

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.